Introduction Type 2 diabetes is reaching pandemic levels and young-onset type 2 diabetes
is becoming increasingly common. Erectile dysfunction (ED) is a common and distressing …

Metabolic syndrome (MetS) is highly prevalent, affecting more than 47 million US residents.
This condition is also multifaceted, potentially leading to significant disturbance of numerous …

Background—Erectile dysfunction (ED) is associated with coronary artery disease (CAD). In
diabetic patients, CAD is often silent. Among diabetic patients with silent CAD, the …

This is our first presentation of Great Drug Classes, and we start with a description of
phosphodiesterase type 5 inhibitors and their use in erectile dysfunction. This is an in‐depth …

The exchange of solutes between the blood and the nerve tissue is mediated by specific and
high selective barriers in order to ensure the integrity of the different compartments of the …

The treatment for erectile dysfunction (ED) was revolutionized with the development of
phosphodiesterase type 5 (PDE5) inhibitors. Tadalafil (Cialis®; Eli Lilly and Company …

Introduction Among men with diabetes, little attention has been given to premature
ejaculation (PE), reduced libido, and their associations with erectile dysfunction (ED) …

In the past 30 years, advances in basic science have been instrumental in the evolution of
the male sexual health treatment paradigm from a psychosexual model to a new model …

OBJECTIVE: Review the literature on phosphodiesterase type 5 inhibitors (PDE5-Is),
addressing critical issues in their current and future use, assessing unanswered questions …

Diabetes can be described as a syndrome of multiple closely related conditions induced by
a chronic state of hyperglycaemia resulting from defective insulin secretion, insulin action or …